Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA
HA Blair - Drugs & Therapy Perspectives, 2019 - Springer
Abstract Wixela® Inhub® is the first therapeutically equivalent, substitutable generic version
of Advair Diskus®(fluticasone propionate/salmeterol) approved for the treatment of asthma …
of Advair Diskus®(fluticasone propionate/salmeterol) approved for the treatment of asthma …
Clinical bioequivalence of Wixela Inhub and Advair Diskus in adults with asthma
D Ng, EM Kerwin, MV White, SD Miller… - Journal of aerosol …, 2020 - liebertpub.com
Background: Wixela® Inhub® is a dry powder inhaler approved as a generic equivalent to
Advair® Diskus®(fluticasone propionate [FP]/salmeterol fixed-dose combination) for patients …
Advair® Diskus®(fluticasone propionate [FP]/salmeterol fixed-dose combination) for patients …
The Role of ICS/LABA Fixed‐Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate‐Salmeterol Device
DP Tashkin, JA Ohar, A Koltun, R Allan… - Pulmonary …, 2021 - Wiley Online Library
Both asthma and chronic obstructive pulmonary disease (COPD) are inflammatory chronic
respiratory conditions with high rates of morbidity and mortality worldwide. The objectives of …
respiratory conditions with high rates of morbidity and mortality worldwide. The objectives of …
Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick®): A Review in Asthma
J Paik, LJ Scott, RA Pleasants - Clinical Drug Investigation, 2018 - Springer
The novel, easy-to-use, breath-actuated fluticasone propionate/salmeterol multidose dry
powder inhaler (MDPI)(AirDuo RespiClick®) was recently approved in the USA for twice …
powder inhaler (MDPI)(AirDuo RespiClick®) was recently approved in the USA for twice …
Wixela inhub: a generic equivalent treatment option for patients with asthma or COPD
JF Donohue, DS Burgoyne, JK Ward, R Allan… - Pulmonary …, 2021 - Springer
Purpose The purpose of this review is to discuss the development of Wixela™ Inhub™, a
generic equivalent of Advair Diskus®, a fixed-dose combination of fluticasone …
generic equivalent of Advair Diskus®, a fixed-dose combination of fluticasone …
Wixela® Inhub® Dry Powder Inhaler-In Vitro Performance Compared with Advair Diskus and Inhalation Profiles in Patients with Asthma or Chronic Obstructive …
A Cooper, C Newcomb, R Wallace… - A64. CLINICAL …, 2019 - atsjournals.org
RATIONALE Wixela Inhub is a fluticasone propionate/salmeterol dry powder inhaler
developed in three strengths (100/50, 250/50, and 500/50 µg) as a generic equivalent of …
developed in three strengths (100/50, 250/50, and 500/50 µg) as a generic equivalent of …
Fluticasone furoate/vilanterol dry-powder inhaler in asthma: a guide to its use in the EU
ED Deeks, KA Lyseng-Williamson, YY Syed - Drugs & Therapy …, 2017 - Springer
Fluticasone furoate/vilanterol [Relvar®, Revinty®(EU); Breo®(USA)], a fixed-dose
combination of an inhaled corticosteroid (ICS) and a long-acting β2-adrenoreceptor agonist …
combination of an inhaled corticosteroid (ICS) and a long-acting β2-adrenoreceptor agonist …
[引用][C] Pharmacokinetic bioequivalence of two fluticasone propionate/salmeterol dry powder inhalers, OT329 Solis, and Advair Diskus
EB Getz, K Carroll - Chest, 2017 - journal.chestnet.org
PURPOSE: OT329 Solis® 100/50 (Oriel Therapeutics, Morrisville, NC, USA) was developed
as a fully substitutable generic to Advair Diskus® 100/50 (GSK, Research Triangle Park, NC …
as a fully substitutable generic to Advair Diskus® 100/50 (GSK, Research Triangle Park, NC …
A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma
L Mansfield, G Yiu, A Sakov, S Liu… - Allergy and Asthma …, 2017 - ingentaconnect.com
Background: A novel multidose dry powder inhaler (MDPI) that is breath actuated, easy, and
intuitive to use has been developed for administering fluticasone propionate (Fp) and …
intuitive to use has been developed for administering fluticasone propionate (Fp) and …
In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles
T Shepherd, M Kennett, A Cooper… - Journal of Aerosol …, 2022 - liebertpub.com
Background: Wixela Inhub (trademarks of Viatris, Inc.) is a dry powder inhaler (DPI) that
delivers a fixed-dose combination of fluticasone propionate and salmeterol and is approved …
delivers a fixed-dose combination of fluticasone propionate and salmeterol and is approved …